KLS-13019
KLS-13019 is an experimental neuroprotective agent that is being developed by Kannalife Sciences, a biopharmaceutical company. It is a novel cannabidiol-like compound that has shown potential in the treatment of neuropathic pain and neurodegenerative diseases such as Parkinson's disease and Huntington's disease.
Chemistry
KLS-13019 is a synthetic, non-psychoactive cannabinoid derivative. It is structurally similar to cannabidiol, a naturally occurring compound found in the cannabis plant. However, KLS-13019 has been modified to enhance its neuroprotective properties and reduce potential side effects.
Pharmacology
The exact mechanism of action of KLS-13019 is not fully understood. However, it is believed to work by modulating the endocannabinoid system, a complex cell-signaling system involved in various physiological processes. KLS-13019 has been shown to have a higher binding affinity for the CB1 receptor and CB2 receptor, the two main cannabinoid receptors in the body, compared to cannabidiol.
Clinical significance
Preclinical studies have shown that KLS-13019 has potent neuroprotective effects. It has been found to prevent neuronal cell death and reduce oxidative stress, a key factor in the development of neurodegenerative diseases. In addition, KLS-13019 has demonstrated analgesic properties, suggesting its potential use in the management of neuropathic pain.
Research
As of 2021, KLS-13019 is in the preclinical stage of development. Kannalife Sciences has conducted several in vitro and in vivo studies to evaluate the safety and efficacy of the compound. The results have been promising, with KLS-13019 showing superior neuroprotective and analgesic effects compared to cannabidiol. However, further research is needed to confirm these findings and determine the optimal dosage and administration route.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD